Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study

BACKGROUND: The use of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) carries a risk of renal function deterioration in cirrhotic patients with ascites. However, whether the long-term use of ACEis/ARBs is safe in cirrhotic patients without ascites remains u...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gastroenterol Res Pract
Main Authors: Hsu, Wei-Fan, Yu, Shi-Hang, Lin, Jaw-Town, Wu, Jaw-Ching, Hou, Ming-Chih, Huang, Yi-Hsiang, Wu, Chun-Ying, Peng, Cheng-Yuan
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811787/
https://ncbi.nlm.nih.gov/pubmed/31687012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1743290
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares